Kausikh Therapeutics Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Kausikh Therapeutics Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $960.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kausikh Therapeutics Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $960.4K Trade | TransData Nexus

Kausikh Therapeutics Private Limited

Indian Pharmaceutical Exporter · Vitamins & Supplements Specialist · $960.4K Total Trade · DGFT Verified

Kausikh Therapeutics Private Limited is an Indian pharmaceutical exporter with a total trade value of $960.4K across 3 products in 2 therapeutic categories. Based on 41 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Iron ($400.0K), Magnesium ($350.0K), Propranolol ($210.4K).

Kausikh Therapeutics Private Limited — Export Portfolio & Destination Treemap

Kausikh Therapeutics Private Limited pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Kausikh Therapeutics Private Limited? — Company Overview & Market Position

Kausikh Therapeutics Private Limited, established on April 19, 2000, is a privately held pharmaceutical company headquartered in Gerugambakkam, Tamil Nadu, India. The company specializes in the manufacture of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, catering to both domestic and international markets. With an authorized and paid-up capital of ₹5.00 crore, Kausikh Therapeutics operates as a non-government company under the Corporate Identification Number (CIN) U24232TN2000PTC044776.

The company's manufacturing facility is located at No. 6 & 7, Door No. 728, Kakkanji Cross Street, Paraniputhur Road, Gerugambakkam, Tamil Nadu, 600122. Kausikh Therapeutics employs approximately 161 professionals, reflecting its commitment to quality and operational excellence. The company's website, www.kausikh.com, provides further insights into its product offerings and corporate philosophy.

What Does Kausikh Therapeutics Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Iron$400.0K 2

Product Portfolio — Top 3 by Export Value

Kausikh Therapeutics Private Limited exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Iron	Vitamins & Supplements	$400.0K	8	0.1%	7
2	Magnesium	Vitamins & Supplements	$350.0K	7	0.1%	7
3	Propranolol	Cardiovascular	$210.4K	26	0.4%	11

Kausikh Therapeutics Private Limited exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $960.4K. The top category is Vitamins & Supplements (78.1% of portfolio), followed by Cardiovascular (21.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Kausikh Therapeutics Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Kausikh Therapeutics operates a state-of-the-art manufacturing plant in Gerugambakkam, Tamil Nadu, which adheres to stringent current Good Manufacturing Practice (cGMP) guidelines. This facility is equipped to produce a wide range of advanced and finished dosage forms, including tablets, capsules, syrups, and injections. The company's emphasis on quality is evident in its commitment to meeting world-class standards, satisfying norms for multinational and large pharmaceutical companies.

3Key Leadership

The leadership team at Kausikh Therapeutics comprises:

Vaidhyanathen Neelakantan: Managing Director, appointed on April 19, 2000.

Vaidhyanathan Ramasubrahmanian: Director, appointed on April 19, 2000.

Anantharamkrishnan Vaidhyanathen: Director, appointed on April 19, 2000.

These individuals have been instrumental in steering the company towards its current position in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Kausikh Therapeutics Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Kausikh Therapeutics has established a presence in various regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has undertaken regulatory filings and approvals to access these markets, demonstrating its commitment to meeting international standards. While specific details of these approvals are not publicly disclosed, the company's adherence to cGMP guidelines and its focus on quality manufacturing suggest a proactive approach to regulatory compliance.

2Emerging Markets

Kausikh Therapeutics has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's commitment to quality and adherence to international standards, such as cGMP, positions it favorably for WHO prequalification, which is essential for accessing these markets. By focusing on quality and compliance, Kausikh Therapeutics aims to meet the growing demand for pharmaceutical products in these regions.

3Geographic Strategy

Kausikh Therapeutics has strategically diversified its geographic footprint by entering both regulated and emerging markets. This approach mitigates concentration risk and leverages growth opportunities across different regions. The company's focus on quality manufacturing and adherence to international standards supports its strategic direction, enabling it to cater to a broad spectrum of markets.

Kausikh Therapeutics Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Kausikh Therapeutics' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's commitment to quality manufacturing and adherence to cGMP guidelines suggest a proactive approach to meeting FDA standards. The absence of publicly available information may indicate that the company is in the process of obtaining or maintaining FDA approvals.

2WHO & EU GMP

Kausikh Therapeutics' adherence to stringent cGMP guidelines indicates a commitment to quality manufacturing. While specific certifications such as WHO prequalification and EU Good Manufacturing Practice (GMP) certificates are not publicly disclosed, the company's focus on quality and compliance suggests that it is well-positioned to meet the requirements for these certifications. Achieving such certifications would further validate the company's manufacturing practices and facilitate access to international markets.

3CDSCO & Indian Regulatory

Kausikh Therapeutics Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Kausikh Therapeutics operates in a competitive pharmaceutical industry, with numerous companies offering similar products in the vitamins & supplements and cardiovascular therapeutic categories. While specific market share data is not publicly available, the company's focus on quality manufacturing and adherence to international standards positions it favorably in the market. The absence of publicly available information on top competitors and their market shares suggests that Kausikh Therapeutics may not be a market leader in its categories.

2Key Differentiators

Kausikh Therapeutics' key differentiators include its commitment to quality manufacturing, adherence to cGMP guidelines, and a diverse product portfolio encompassing vitamins & supplements and cardiovascular products. The company's focus on contract research and customer-oriented manufacturing systems allows it to offer formulations in various languages and third-party names, catering to client specifications.

3Strategic Position

Kausikh Therapeutics' current strategic direction focuses on contract research and manufacturing services, offering both generic products developed in-house and contract manufacturing services to pharmaceutical marketing companies. This approach allows the company to cater to a broad spectrum of market needs, from generic formulations to customized manufacturing solutions. The company's commitment to quality and adherence to international standards positions it well for future growth and expansion in both domestic and international markets.

Buyer Due Diligence Brief — Evaluating Kausikh Therapeutics Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Kausikh Therapeutics has demonstrated a consistent track record in manufacturing and exporting pharmaceutical formulations, with a total export value of $960,000 USD across 41 shipments from 2022 to 2026. The company's portfolio includes three products across two therapeutic categories, with a concentration in vitamins & supplements (78.1%) and cardiovascular products (21.9%). The top three products—Iron, Magnesium, and Propranolol—account for 100% of the company's export value, indicating a focused product strategy. The company's adherence to cGMP guidelines and commitment to quality manufacturing further enhance its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the company's products are approved by the U.S. Food and Drug Administration (FDA) by checking the FDA's official database.

WHO-GMP Certification: Verify that the manufacturing facility complies with World Health Organization Good Manufacturing Practice (GMP) standards by consulting the WHO's official listings.

Frequently Asked Questions — Kausikh Therapeutics Private Limited

How many pharmaceutical products does Kausikh Therapeutics Private Limited export from India?

Kausikh Therapeutics Private Limited exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Iron ($400.0K), Magnesium ($350.0K), Propranolol ($210.4K). Total export value is $960.4K.

What is Kausikh Therapeutics Private Limited's total pharmaceutical export value?

Kausikh Therapeutics Private Limited's total pharmaceutical export value is $960.4K, based on 41 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Kausikh Therapeutics Private Limited cover?

Kausikh Therapeutics Private Limited exports across 2 therapeutic categories. The largest are Vitamins & Supplements (78.1%, 2 products), Cardiovascular (21.9%, 1 products).

Get Full Kausikh Therapeutics Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.